Beneficial ownership — 13D / 13G
87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Heilbron Jack Kendrick | SQFT Presidio Property Trust, Inc. | 13D | 7.8% | Jan 5, 2024 | 2y |
| AQR CAPITAL MANAGEMENT LLC | SUAC ShoulderUp Technology Acquisition Corp. | 13G | 12% | Dec 31, 2023 | 2y |
| STATE STREET CORP | KRC Kilroy Realty Corp | 13G/A | 5.43% | Dec 31, 2023 | 2y |
| Perry A. Sook | NXST Nexstar Media Group, Inc. | 13G | 5.2% | Dec 31, 2023 | 2y |
| Aspex Management (HK) Ltd | QFIN Qfin Holdings, Inc. | 13G/A | 5.3% | Dec 31, 2023 | 2y |
| Group of Trophy, LLC | GIPR Generation Income Properties, Inc. | 13G/A | 0% | Feb 29, 2024 | 2y |
| BBAI Ultimate Holdings, LLC | BBAI BigBear.ai Holdings, Inc. | 13D/A | 75.2% | Feb 29, 2024 | 2y |
| Hood River Capital Management LLC | DCGO DocGo Inc. | 13G/A | 1.7% | Feb 29, 2024 | 2y |
| Trilogy Equity Partners, LLC | OWLT Owlet, Inc. | 13D/A | 23.9% | Feb 29, 2024 | 2y |
| Smiths Group plc | ICUI Icu Medical Inc | 13D/A | 6.9% | Feb 29, 2024 | 2y |
| First City Investment Group, LLC | GIPR Generation Income Properties, Inc. | 13G | 6.8% | Feb 29, 2024 | 2y |
| Alessandra T. Norcross | FRBK Republic First Bancorp Inc | 13D/A | 3.7% | Feb 29, 2024 | 2y |
| BCLS II Investco, LP | NAMS NewAmsterdam Pharma Co N.V. | 13D/A | 6% | Feb 28, 2024 | 2y |
| Blackstone Inc. | APG APi Group Corp | 13D/A | 4.8% | Feb 28, 2024 | 2y |
| BRC Group Holdings, Inc. | MCHX Marchex Inc | 13G/A | 4% | Feb 28, 2024 | 2y |
| Charles F. Dolan | SPHR Sphere Entertainment Co. | 13D/A | 12.9% | Feb 28, 2024 | 2y |
| BIOS EQUITY PARTNERS, LP | LTRN Lantern Pharma Inc. | 13D/A | 11.8% | Feb 28, 2024 | 2y |
| Morris Willner | ARKO ARKO Corp. | 13D/A | 9.74% | Feb 28, 2024 | 2y |
| David R. Parker and Jacqueline F. Parker | CVLG Covenant Logistics Group, Inc. | 13D/A | 30.8% | Feb 28, 2024 | 2y |
| Elliott Investment Management L.P. | BTU Peabody Energy Corp | 13D/A | 4.6% | Feb 28, 2024 | 2y |
| Coliseum Capital Management, LLC | GMS GMS Inc. | 13D/A | 4.9% | Feb 28, 2024 | 2y |
| Fund 1 Investments, LLC | CTRN Citi Trends Inc | 13D/A | 16.8% | Feb 28, 2024 | 2y |
| VIKING GLOBAL INVESTORS LP | APG APi Group Corp | 13G/A | 12.3% | Feb 28, 2024 | 2y |
| JAY S. HENNICK | CIGI Colliers International Group Inc. | 13D/A | 13.1% | Feb 28, 2024 | 2y |
| Ariel Emanuel | EDR Endeavor Group Holdings, Inc. | 13D/A | 11.9% | Feb 26, 2024 | 2y |
| GP Cash Management, Ltd. | IZEA IZEA Worldwide, Inc. | 13G | 6.1% | Feb 23, 2024 | 2y |
| David T. Lu | BHM Bluerock Homes Trust, Inc. | 13G/A | 8.7% | Feb 23, 2024 | 2y |
| Nelson Michael Aaron | BLPH Bellerophon Therapeutics, Inc. | 13G | 5.3% | Feb 22, 2024 | 2y |
| Aperture Healthcare Ventures Ltd. | PTHS Pelthos Therapeutics Inc. | 13G | 7.7% | Feb 21, 2024 | 2y |
| 3i, LP | PTHS Pelthos Therapeutics Inc. | 13G | 5.5% | Feb 21, 2024 | 2y |
| AME Equities LLC | PTHS Pelthos Therapeutics Inc. | 13G | 6.4% | Feb 21, 2024 | 2y |
| Benuvia Operations, LLC | PTHS Pelthos Therapeutics Inc. | 13G | 6.7% | Feb 21, 2024 | 2y |
| Motif Pharmaceuticals Ltd. | PTHS Pelthos Therapeutics Inc. | 13G | 8.4% | Feb 21, 2024 | 2y |
| PERCEPTIVE ADVISORS LLC | IOVA Iovance Biotherapeutics, Inc. | 13G | 6.9% | Feb 20, 2024 | 2y |
| 683 Capital Management, LLC | MODD Modular Medical, Inc. | 13G | 6.99% | Feb 16, 2024 | 2y |
| WOLVERINE ASSET MANAGEMENT LLC | FTII FutureTech II Acquisition Corp. | 13G/A | 4.44% | Feb 14, 2024 | 2y |
| Rosalind Advisors, Inc. | PYPD PolyPid Ltd. | 13G | 9.95% | Feb 13, 2024 | 2y |
| WOLVERINE ASSET MANAGEMENT LLC | IRRX Integrated Rail and Resources Acquisition Corp. | 13G/A | 2.61% | Feb 12, 2024 | 2y |
| WOLVERINE ASSET MANAGEMENT LLC | SBC SBC Medical Group Holdings Inc | 13G/A | 0% | Feb 5, 2024 | 2y |
| Suntone Investment Pty Ltd | WELNF Integrated Wellness Acquisition Corp | 13D | 69.6% | Feb 1, 2024 | 2y |
| Peter Luo | ADAG Adagene Inc. | 13D/A | 21.28% | Jan 19, 2024 | 2y |
| Quarry LP | SEDA SDCL EDGE Acquisition Corporation | 13G | 7.5% | Dec 31, 2023 | 2y |
| Carl Daikeler | BODI Beachbody Company, Inc. | 13D/A | 38.7% | Dec 13, 2023 | 2y |
| PERCEPTIVE ADVISORS LLC | CRNX Crinetics Pharmaceuticals, Inc. | 13D/A | 1.9% | May 24, 2023 | 2y |
| Sachem Head Capital Management LP | USFD US Foods Holding Corp. | 13D/A | 6.5% | Feb 28, 2024 | 2y |
| ZUU Co. Ltd. | SBC SBC Medical Group Holdings Inc | 13D/A | 25.5% | Feb 28, 2024 | 2y |
| DE AGOSTINI SPA | BRSL Brightstar Lottery PLC | 13D/A | 42.6% | Feb 28, 2024 | 2y |
| Panasonic Holdings Corporation | NMG Nouveau Monde Graphite Inc. | 13G | 17% | Feb 28, 2024 | 2y |
| Point72 Asset Management, L.P. | LUNG Pulmonx Corp | 13G | 5% | Feb 28, 2024 | 2y |
| Saba Capital Management, L.P. | DHF Bny Mellon High Yield Strategies Fund | 13D/A | 4.11% | Feb 27, 2024 | 2y |